Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 11 03 2023
revised: 14 08 2023
accepted: 25 09 2023
pubmed: 27 9 2023
medline: 27 9 2023
entrez: 27 9 2023
Statut: ppublish

Résumé

Cancer mortality primarily stems from metastatic recurrence, emphasizing the urgent need for developing effective metastasis-targeted immunotherapies. To better understand the cellular and molecular events shaping metastatic niches, we used a spontaneous breast cancer lung metastasis model to create a single-cell atlas spanning different metastatic stages and regions. We found that premetastatic lungs are infiltrated by inflammatory neutrophils and monocytes, followed by the accumulation of suppressive macrophages with the emergence of metastases. Spatial profiling revealed that metastasis-associated immune cells were present in the metastasis core, with the exception of TREM2+ regulatory macrophages uniquely enriched at the metastatic invasive margin, consistent across both murine models and human patient samples. These regulatory macrophages (Mreg) contribute to the formation of an immune-suppressive niche, cloaking tumor cells from immune surveillance. Our study provides a compendium of immune cell dynamics across metastatic stages and niches, informing the development of metastasis-targeting immunotherapies. Temporal and spatial single-cell analysis of metastasis stages revealed new players in modulating immune surveillance and suppression. Our study highlights distinct populations of TREM2 macrophages as modulators of the microenvironment in metastasis, and as the key immune determinant defining metastatic niches, pointing to myeloid checkpoints to improve therapeutic strategies. This article is featured in Selected Articles from This Issue, p. 2489.

Identifiants

pubmed: 37756565
pii: 731625
doi: 10.1158/2159-8290.CD-23-0299
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2610-2631

Subventions

Organisme : U.S. Department of Defense (DOD)
ID : W81XWH2110394
Organisme : HORIZON EUROPE European Research Council (ERC)
ID : 101055341-TROJAN-Cell
Organisme : Israel Science Foundation (ISF)
ID : 1090/18
Organisme : Israel Cancer Research Fund (ICRF)
Organisme : Worldwide Cancer Research (WCR)
Organisme : Israel Science Foundation (ISF)
ID : #3495/19
Organisme : Israel Cancer Research Fund (ICRF)
Organisme : Emerson Collective (Emerson)

Informations de copyright

©2023 American Association for Cancer Research.

Auteurs

Ido Yofe (I)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Tamar Shami (T)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Noam Cohen (N)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Tomer Landsberger (T)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Fadi Sheban (F)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Liat Stoler-Barak (L)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Adam Yalin (A)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Truong San Phan (TS)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Baoguo Li (B)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Lea Monteran (L)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ye'ela Scharff (Y)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amir Giladi (A)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Miriam Elbaz (M)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Eyal David (E)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Anna Gurevich-Shapiro (A)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Chamutal Gur (C)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Ziv Shulman (Z)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Neta Erez (N)

Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ido Amit (I)

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

Classifications MeSH